2, 4, 6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2005236063 (hide)

Owner Merck & Co., Inc.

Inventors Selnick, Harold G.; Stachel, Shawn J.; Rajapakse, Hemaka A.; Vacca, Joseph P.; Coburn, Craig A.; Stauffer, Shaun R.; McGaughey, Georgia B.; Nantermet, Philippe G.; Stanton, Matthew G.; Barrow, James C.

Agent Spruson & Ferguson

Pub. Number AU-A-2005236063

PCT Pub. Number WO2005/103043

Priority 60/630,539 23.11.04 US; 60/563,612 20.04.04 US; 60/653,037 15.02.05 US

Filing date 20 April 2005

Wipo publication date 3 November 2005

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/103043 Priority application(s): WO2005/103043

18 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005236064-RNAI-based target identification and validation

2005236061-Composition suitable for single-sided, low-noise, stretch cling film and films made therefrom